Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > somethings gotta give...
View:
Post by Yajne on Jan 22, 2023 12:23am

somethings gotta give...

I've gotta believe that TLT hasn't shown all of their cards to address the financing issue that's soon approaching. My math suggests they raised enough pp funds to get to the end of Q1 (Mar31/23). They must already know of a JV in the works or something to remain solvent past Q1. I'm optimistic that there is a game plan in the works, but something definitely has gotta give soon...GLTA all longs!!
Comment by CancerSlayer on Jan 22, 2023 1:44am
  Yep...Big Pharma will flex its $ leverage regardless of partnership type, but would rather have them flex leverage in the form of a JV.  They would certainly otherwise be looking for a fire sale buyout price at this juncture.  It's going to be a tight race between two timelines:  BTD/sp increase & the need for cash...let's hope the former finishes first.
Comment by Legit62 on Jan 22, 2023 9:26am
After all these years CancerSlayer, doubt very very much there will be a fire sale with Roger, waiting patiently. Enjoy the ride
Comment by Rumpl3StiltSkin on Jan 22, 2023 9:44am
I don't know Yajne, I was thinking they had enough to get to the fall of 23. Maybe mine is wrong??
Comment by Rumpl3StiltSkin on Jan 22, 2023 9:49am
 Either way though, whenever that $$ is gonna run out. I think they will have a much higher SP by then. And I also think you are right about advanced $$ talks with some Bio/Pharma...
Comment by plantrader on Jan 22, 2023 11:27am
Would that mean we think Dr Mandel was sandbagging in the recent article? Since he said the company expects to get into talks with big biopharma in 2023/24? If they were already in advanced talks why would he make it sound like it hasn't started yet?  Maybe misdirection is common in a situation like this, I personally don't know. But this seems similar to expecting BTD in Feb when ...more  
Comment by N0taP00p on Jan 22, 2023 12:13pm
@Plantrader- Like you and a couple of others here, I'm sipping the Koolaid from a very small straw.  I really hope the optimistic views expressed here come true but I also keep noticing how the wording with each NR subtly adds in delays. Both for ACT and vaccine.  Something about not being able to raise any money in the last round still rankles with me. And I've been through ...more  
Comment by plantrader on Jan 22, 2023 12:20pm
N0ta, I know what you mean. It doesn't do us any good to set overly optimistic expectations in our minds at this point IMO. I'm telling myself not to expect to hear anything until at least April. And that's based on the extrapolating company's own words, not something I've fabricated in my own head.  Thanks to members of this board I've gotten a little bit better ...more  
Comment by Longholder99 on Jan 22, 2023 1:00pm
Underpromise and overdeliver I think is more the case in terms of Dr Mandels' carefully chosen words. Likely that some preliminary talks have happened but won't be released as actual info until RDW is back as CEO.  We are 2mos out in my opinion from it all hitting the ground.  6 weeks maybe.  Depending on what the deal is we could be looking at a serious SP jump as those who ...more  
Comment by Oilminerdeluxe on Jan 22, 2023 1:42pm
Was it end of Feb Roger could return? If that is indeed the plan.
Comment by CAinPlap on Jan 23, 2023 10:10am
Date of order was Feb 16, 2018. 
Comment by FGPstock on Jan 23, 2023 12:42pm
imo, putting roger back to the CEO position 5 years after his settlement is a business mistake. On most exchanges, he would be banned from being part of any public company. He is the one that admittedly committed fraud, and the ppl by his side are the current CEO and CFO. That being said, they will probably put him back as there is no one on the BOD or management that will say no to him. In ...more  
Comment by skys1 on Jan 23, 2023 1:13pm
As I have posted several times previously IMO, FGP is a very smooth professional basher. Go look at all his posts. In everty one he trashes the Company, then tells us he is a big long time shareholder. Yeah sure! 
Comment by FGPstock on Jan 23, 2023 1:20pm
my opinion may be different that yours, but i do own a few shares. no sure why asking for transparency is a bad thing, it is a public company.
Comment by FGPstock on Jan 23, 2023 1:24pm
Comment by Longholder99 on Jan 23, 2023 1:31pm
Saw that right off the hop.  Have had him/her on ignore pretty much from bash #1.
Comment by FGPstock on Jan 23, 2023 1:38pm
probably not as much as u all, but should allow me the right to an opinion, everything I posted is 100% true. How can the truth b bashing? Stocks View: Stock (default) *Most data is streaming, but values marked with * update every 5 minutes. 1:35:28 pm ET 1/23/23 Update now Current value: $484,435.63 $14,292.03 Symbol Account Qty Price Chg ($) Cost Mkt value * Maint req Gain ($) * TLTFF -- 1,745 ...more  
Comment by Legit62 on Jan 22, 2023 2:15pm
Agree with you Longholder 99, play by the rules , waiting for Roger, conservative vague statements
Comment by CancerSlayer on Jan 22, 2023 3:38pm
  I am in that underpromise & overdeliver camp.   With that in mind, my interpretation of Dr. Mandel's statement, "the company plans to apply for FDA breakthrough drug designation in the first quarter of 2023 on the basis of the Phase 2 clinical study data collected to date"     leads me to believe the deal/partnership timeline is probably more than 2 ...more  
Comment by Longholder99 on Jan 22, 2023 6:08pm
CancerSlayer I agree too that timeliness have a way of being longer...way longer.  Only consideration giving this hope of a faster turnaround for me is the delays with patient numbers may have given time for the homework to already be done.  I wonder if the decision to proceed with a JV is only waiting for the BTD approval.  Merck.  Roche.  Whoever has been watching this ...more  
Comment by patience69 on Jan 22, 2023 6:35pm
Again maybe this is wishful thinking or I am nuts but here is my thought on timing. Does anyone think that it could have be possible that Dr Vera was in place  on behalf of a suitor? Someone who wanted to do the deep dive into the books?  Maybe make up their mind what their parameters would be in order to do a jv? It is  just a recurring thought that I have had. It would sure ...more  
Comment by CancerSlayer on Jan 22, 2023 7:43pm
  In my mind, in order to maximize a favorable deal-making outcome, we should have a predetermined  catalyst in mind that would trigger "multiple" suitors (preferably at least two), & then do everything possible (within reason) to hold out until that moment....more than two interested Pharmas would have the potential to drive an even more aggressive bidding war & a ...more  
Comment by Rumpl3StiltSkin on Jan 22, 2023 10:06pm
I think if the CR numbers are as good as we hope shouldn't the BTD just be a formality to achieving AA? And will speed up the overall timeline?
Comment by StevenBirch on Jan 23, 2023 7:36am
Rump, I think your original comment about advanced talks is correct. Dr. Mandel plays it close to the vest but when he says partnering talks I think that's what he means as I'm sure they have had preliminary talks all along. With the critical data in or about to be in and BTD to follow it seems actual deals are to be discussed. I want to see where we go even with just BTD? That has to be ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250